Pre-and Post-Transplant Serum Lactate Dehydrogenase Levels as a Predictive Marker for Patient Survival and Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients | Zendy

Elham Roshandel | Zendy; Sayeh Parkhideh | Zendy; Haniyeh GhaffariNazari | Zendy; Mahshid Mehdizadeh | Zendy; Hossein Bonakchi | Zendy; Ghazaleh Sankanian | Zendy; Abbas Hajifathali | Zendy

Open Access

Pre-and Post-Transplant Serum Lactate Dehydrogenase Levels as a Predictive Marker for Patient Survival and Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Author(s) -

Elham Roshandel,

Sayeh Parkhideh,

Haniyeh GhaffariNazari,

Mahshid Mehdizadeh,

Hossein Bonakchi,

Ghazaleh Sankanian,

Abbas Hajifathali

Publication year - 2021

Publication title -

reports of biochemistry and molecular biology

Language(s) - English

Resource type - Journals

ISSN - 2322-3480

DOI - 10.52547/rbmb.10.2.204

Subject(s) - medicine , hematopoietic stem cell transplantation , transplantation , incidence (geometry) , white blood cell , graft versus host disease , oncology , immunology , gastroenterology , physics , optics

The discovery of biomarkers to predict the development of complications associated with hematopoietic stem cell transplantation (HSCT) offers a potential avenue for the early identification and treatment of these life-threatening consequences. Serum lactate dehydrogenase (sLDH) has been identified as a potential biomarker for determining the outcome of allogenic HSCT (allo-HSCT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research